Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee
Completed
Conditions studied: Anesthesia, Local
In brief
Serum levels of bupivacaine over time after peri-articular injection of a mixture of liposomal bupivacaine and plain bupivacaine during total knee arthroplasty.
Key facts
- Study ID
- NCT02626559
- Run by
- University of Utah
- People needed
- 40
- Starts
- 2015-11-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2016-12-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adults of at least 18 years of age having a primary, unilateral total knee arthroplasty with a surgical plan to have an intra-articular injection of a mixture of 266 mg of Exparel, 125 mg of bupivacaine, 1:300,000 epinephrine, and 0.9% saline to make a total volume of 100 ml.
You may not qualify if…
- Known hepatic dysfunction or renal insufficiency (creatinine > 1.5 mg/dL);
- allergy to the study medications;
- pregnancy;
- incarceration;
- inability to communicate with the investigators;
- morbid obesity (body mass index > 40 kg/m2).
Where it is running
- Uutah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.